Bristol Myers Squibb (BMY) Restructuring Costs (2009 - 2013)

Bristol Myers Squibb (BMY) has reported Restructuring Costs for 5 consecutive years, with $33.0 million the latest figure, recorded in Q1 2013.

• On a quarterly basis, Restructuring Costs rose 50.0% year-over-year to $33.0 million in Q1 2013; TTM through Mar 2013 was $185.0 million, a 96.81% increase from a year earlier, with the FY2012 full-year figure at $174.0 million, up 50.0% from the prior year.
• Restructuring Costs was $33.0 million for Q1 2013 at Bristol Myers Squibb, down from $103.0 million in the prior quarter.
• Over five years, Restructuring Costs peaked at $103.0 million in Q4 2012 and troughed at $8.0 million in Q3 2011.
• A 5-year average of $33.6 million and a median of $24.0 million in 2010 frame the typical range for Restructuring Costs.
• Across the five-year window, Restructuring Costs sank 70.59% in 2010 and soared 329.17% in 2012, its largest moves.
• Over 5 years, Restructuring Costs stood at $47.0 million in 2009, then surged by 34.04% to $63.0 million in 2010, then plunged by 61.9% to $24.0 million in 2011, then soared by 329.17% to $103.0 million in 2012, then plunged by 67.96% to $33.0 million in 2013.
• The last three Restructuring Costs figures came in at $33.0 million (Q1 2013), $103.0 million (Q4 2012), and $29.0 million (Q3 2012), per Business Quant data.